High Throughput Screening Core

项目总结 该计划的总体目标是发现和开发用于治疗的小分子口服生物利用药物。 SARS-CoV2和其他具有大流行潜力的病毒。我们的具体角色是提供一个中央核心设施， 使用高通量筛查来识别有效和选择性类药物铅的专业知识和技术 并进一步表征这些化合物的浓度-反应关系，亲和力， 所选分子靶标的化学计量学、离散率、熵贡献和结合热。我们会 还支持高通量表型分析中的抗病毒效果测试。我们打算与 项目负责人和药物化学家迅速获得有关其作用机制的关键信息 从筛选中确定的化学支架中衍生出来的各种化合物，并支持 药物化学计划测试改进的同系物对初级药物的效力和选择性 目标。

PROJECT SUMMARY The overall goal of this program is to discover and develop small molecule orally bioavailable drugs to treat SARS-CoV2 and other viruses with pandemic potential. Our specific role is to provide a central core facility, with expertise and technologies that use high-throughput screening to identify potent and selective drug-like lead compounds and further characterize these compounds for concentration-response relationships, affinity, stoichiometry, off-rates, contributions of entropy and enthalpy of binding of the chosen molecular targets. We will also support testing in high-throughput phenotypic assays for anti-viral efficacy. We intend to work closely with the project leaders and medicinal chemists to rapidly gain critical information on the mechanism of action of various compounds derived from the chemical scaffolds identified in the screens conducted and to support medicinal chemistry programs in testing improved congeners for potency and selectivity against the primary targets.